Vanberra Signal
Free trial

Qrativ

Curated by Signal

AI based drug purposing platform to identify treatments for rare diseases

Health Technologyqrativ.bio

Overview

Qrative is a joint venture formed by Mayo Clinic & nference to identify treatments for rare diseases using drug purposing approach. The company has developed a propriety drug purposing platform, Darwin.ai, leverages proprietary data from Mayo Clinics (EHRs, prescription & diagnosis data, patient-treatment omics) and nference’s knowledge synthesis AI platform (data extracted from PubMed, Clinical Trials, etc). The company claims that the drug developers can use its platform to identify uses for their molecules at an early phase of development. The company has got $8.3 million funding from Matrix Capital Management, Matrix Partners, and the Mayo Clinic.

Key facts

Founded
2017
Headquarters
Cambridge, United States
Stage
Sign up to view
Industry
Health Technology

Contact

Primary office
Sign up to view

More on Vanberra Signal

Members only
Business overviewCore metrics and financialsPeopleLeadership and key peopleSimilar companiesPeers and competitorsDeep AnalysisAI-generated strategic report

Competitors & similar companies

More Health Technology companies

  • ALD

    Online learning platform for dentists

    Health TechnologyCoral Springs, United States

  • Heal

    Online marketplace for listing wellness practitioners

    Health TechnologyAustin, United States

  • InstaCare

    Healthcare app providing pharmacy care services

    Health TechnologyCharlotte, United States

About Qrativ

What does Qrativ do?

Qrative is a joint venture formed by Mayo Clinic & nference to identify treatments for rare diseases using drug purposing approach.

Where is Qrativ headquartered?

Qrativ is headquartered in Cambridge, United States.

When was Qrativ founded?

Qrativ was founded in 2017.

Which sector is Qrativ in?

Qrativ operates in Health Technology.

Who are Qrativ's competitors?

Companies similar to Qrativ include ALD, Heal, and InstaCare.